AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

Buying for a business?Offer from Amazon

Get business pricing on tech for your team

  • Business-only prices and quantity discounts
  • Tax-exempt purchasing
  • Multiple users, one account, clear invoices
As an affiliate, we earn on qualifying purchases.

Medicare has launched ACCESS, a 10-year program that financially incentivizes AI-based healthcare management focused on patient outcomes. The initiative is a major shift in federal healthcare payments, yet many in the tech sector are unaware of its scope and implications.

Medicare’s new program, ACCESS, officially launched on July 5, establishing a payment model that rewards healthcare outcomes rather than activity, and incorporating AI-driven care solutions at a federal level for the first time.

ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) is a decade-long initiative by the Centers for Medicare & Medicaid Services (CMS) that tests outcome-based reimbursement for managing chronic conditions. It includes participants like AI startups, virtual care providers, and device companies, with the goal of integrating AI into routine care and funding it through new payment mechanisms.

One of the first participants, Pair Team, has been operating since 2019, focusing on underserved populations managing chronic illnesses and social determinants of health. The company employs a voice AI agent, Flora, which handles patient check-ins and care coordination, reducing unnecessary hospital visits. Pair Team was accepted into ACCESS after demonstrating prior success in reducing avoidable hospital and ER visits by up to 25% and 50%, respectively.

Why It Matters

This development signifies a fundamental shift in healthcare reimbursement, moving from activity-based payments to outcome-based models that explicitly fund AI-driven care. It could accelerate AI adoption in healthcare, especially for vulnerable populations, and challenge traditional reimbursement structures.

However, it also exposes risks related to data security, given the sensitive nature of health information fed into federal systems, and questions about whether the model will produce cost savings or simply increase federal spending, as past CMS innovation programs have.

Products Worth Considering

LG 34GX90SA-W 34-inch Ultragear WQHD OLED Curved Gaming Monitor

LG 34GX90SA-W 34-inch Ultragear WQHD OLED Curved Gaming Monitor

As an affiliate, we earn on qualifying purchases.

Background

CMS has experimented with innovation programs over the past decade, with mixed results. ACCESS is a notable effort to directly incentivize AI and outcome-focused care, designed by former startup entrepreneurs within CMS who favor competition and outcome metrics. Prior to this, Medicare primarily reimbursed providers based on visit frequency and procedures, with limited scope for AI integration.

Neil Batlivala, founder of Pair Team, has been developing community health models since 2019, incorporating social determinants and behavioral health, supported by peer-reviewed research showing reduced hospital utilization. The deployment of Flora, an AI voice agent, marked a significant step toward automating patient engagement at scale.

“The government is creating swim lanes for AI innovation in traditionally regulated industries. The best solution wins, which, in regulated industries like healthcare — that’s not been the case.”

— Neil Batlivala

“The program was designed with outcome-based payments, direct-to-consumer enrollment, and a deliberate push for competition.”

— Abe Sutton and Jacob Shiff (CMS Innovation Center)

What Remains Unclear

It remains unclear how widespread AI adoption will become under this model, whether the program will achieve cost savings, and how data security concerns will be addressed at scale. The long-term impact on healthcare costs and quality is still to be observed.

What’s Next

Participants will continue deploying AI solutions and reporting outcomes over the next several years. CMS will monitor performance, adjust reimbursement models, and potentially expand the program based on initial results. Further announcements on program outcomes and policy adjustments are anticipated.

Key Questions

What exactly is the ACCESS program?

ACCESS is a 10-year CMS initiative testing outcome-based payments for managing chronic conditions, with a focus on integrating AI-driven care solutions.

Why is this development significant?

It represents a major shift in healthcare reimbursement, incentivizing AI use and outcome-focused care, potentially transforming how healthcare services are delivered and paid for at a federal level.

Who are the main participants in this program?

Participants include AI startups like Pair Team, virtual care providers, device makers, and other healthcare innovators, all working under new federal payment structures.

What are the risks associated with this program?

Risks include data security concerns due to sensitive health information being fed into federal systems, and questions about whether the program will lead to cost savings or increased federal spending.

What happens next for the program?

Participants will expand their AI applications, CMS will evaluate outcomes, and the program may be scaled or adjusted based on initial results over the coming years.

You May Also Like

Recovery-percentile tracker for orthopedic surgery patients

A new recovery-percentile tracking tool for post-op orthopedic patients is being tested in a pilot, aiming to reduce patient calls and improve recovery monitoring.

The New Role of AI in Hospital Bed Management

A transformative shift in hospital bed management awaits, revealing how AI is redefining efficiency and patient care in ways you need to explore.

AI for Early Detection of Alzheimer’s Disease

Unlock how AI’s early detection advancements could transform Alzheimer’s diagnosis and treatment—discover the future of personalized care today.

Vertigo relief app

A new app aims to help adults with recurrent BPPV perform repositioning maneuvers at home, supported by ENT clinics and physiotherapists.